𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severe Charcot-Marie-Tooth neuropathy type 1A with 1-base pair deletion and frameshift mutation in the peripheral myelin protein 22 gene

✍ Scribed by Victor V. Ionasescu; Charles C. Searby; Rebecca Ionasescu; Ricardo Reisin; Victor Ruggieri; Claudia Arberas


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
82 KB
Volume
20
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis


A 27-year-old man with negative family history and both parents with normal neurological evaluation and motor nerve conduction velocities (MNCVs) showed onset of severe weakness of feet at 4 years of age. Subsequently he developed left equinovarus deformity, thoracic scoliosis, ulnar nerve enlargement, areflexia, distal hypesthesia and slowing of MNCVs for median and ulnar nerves (15-25 m/sec). Molecular genetic studies showed deletion of one nucleotide (G330) (codon 94) in exon 3 of the PMP22 gene associated with frameshift mutation.


πŸ“œ SIMILAR VOLUMES


Screening for mutations in the periphera
✍ Irina V. Mersiyanova; Sookhrat M. Ismailov; Alexandr V. Polyakov; Elena L. Dadal πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 2 views

## Communicated by Mark Paalman Charcot-Marie-Tooth disease (CMT) and related inherited peripheral neuropathies, including Dejerine-Sottas syndrome, congenital hypomyelination, and hereditary neuropathy with liability to pressure palsies (HNPP), are caused by mutations in three myelin genes: PMP22,

A Novel Mutation (D305V) in the early gr
✍ Emilia Bellone; Emilio Di Maria; Silvia Soriani; Alessandra Varese; Laura Lamba πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 18 KB πŸ‘ 2 views

Hereditary motor and sensory neuropathies (HMSN) comprises a wide clinical spectrum of related disorders with defects in peripheral nerve myelination. Charcot-Marie-Tooth type 1 (CMT1) is the most common form and is usually a mild disease with onset in the first or second decade; however there is a

A novel mutation of the protein C gene w
✍ Takahashi, Toru; Shinohara, Kenji; Nawata, Ryohei; Wakiyama, Machiko; Hamasaki, πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 3 views

TABLE I. Colony-Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 Β± 4.6 Control 2 48.5 Β± 14.1 Before chemotherapy 24.4 Β± 6.2 b After chemotherapy 50.5 Β± 6.5 Values are means Β± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a pa

Screening for mutations in the periphera
πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

The authors wish to correct a mistake which occurred in the reporting of one of the mutations. The mutation in Cx32 Met34Lys is wrongly described as 100A>G. The correct description of the mutation should be 101T>A (Met34Lys).